Article
QVT Score, a radiomic biomarker of vascular complexity, enables prognostication and monitoring of NSCLC immunotherapy
2025-09-12
Abstract excerpt
<h4>Background</h4> Immune checkpoint inhibitors (ICIs) improve survival in advanced non-small cell lung cancer (NSCLC), yet current biomarkers such as PD-L1 expression and response criteria (RECIST v1.1) align poorly with long-term survival. Radiomics has been proposed as a source of novel biomarkers, but standard radiomic approaches suffer from limited biological interpretability and poor generalizability acros...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ceaf9a24-0d65-5ab2-acc2-4316e3ae841f
- DOI
- 10.1101/2025.09.08.25335020
